Yahoo
OTC Markets OTCPK - Delayed Quote USD

Petros Pharmaceuticals, Inc. (PTPI)

0.0030 0.0000 (0.00%)
At close: November 10 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0 0 0 5,822.3880 5,992.0540
Cost of Revenue
-1,212.7000 -- -1,212.7000 -1,631.2200 -2,289.4180
Gross Profit
0 0 0 4,191.1680 3,702.6360
Selling, General and Administrative Expenses
-3,397.9040 -4,641.3500 -4,626.9430 -9,261.4710 -12,209.1620
Research and Development Expenses
-2,615.0500 -- -2,615.0500 -2,409.0940 -1,740.2800
Depreciation, Amortization and Depletion
-2,831.2190 -- -2,831.2190 -3,282.9670 -5,598.8840
Operating Income/Expenses
-3,397.9040 -4,641.3500 -4,626.9430 -14,953.5320 -19,548.3260
Total Operating Profit/Loss
-3,397.9040 -4,641.3500 -4,626.9430 -10,762.3640 -15,845.6900
Total Net Finance Income/Expense
192.4140 256.9330 371.7690 -20.8270 -581.8240
Net Investment Income
10,424.5820 10,305.3570 3,550 16,564 460
Irregular Income/Expenses
-7,383.6220 -- -7,383.6220 0 -7,460
Other Income/Expense, Non-Operating
-10,420.9820 -10,420.9820 0 -13,943.9970 3,389.9410
Non-Operating Income/Expenses, Total
196.0140 141.3080 3,921.7690 2,599.1760 -4,191.8830
Pretax Income
-3,201.8900 -4,500.0420 -705.1740 -8,163.1880 -20,037.5730
Provision for Income Tax
0 0 0 0 0
Net Income from Continuing Operations
-3,201.8900 -4,500.0420 -705.1740 -8,163.1880 -20,037.5730
Discontinued Operations
6,973.3020 6,413.6370 -13,613.6160 -- --
Extraordinary Items
0 -- -- -- --
Net Income after Extraordinary Items and Discontinued Operations
-3,201.8900 1,913.5950 -14,318.7900 -8,163.1880 -20,037.5730
Net Income after Non-Controlling/Minority Interests
-3,201.8900 1,913.5950 -14,318.7900 -8,163.1880 -20,037.5730
Preferred/Other Stock Distribution
-11,760.1510 -45,602.8080 -2,308.1220 -821.4560 0
Other Adjustments to Net Income Available to Common Stockholders
6,413.6370 0 -10,170.2470 -4,829.7550 0
Net Income Available to Common Stockholders
-8,548.4040 -43,689.2130 -26,797.1590 -13,814.3990 -20,037.5730
Diluted Net Income Available to Common Stockholders
-8,548.4040 -43,689.2130 -26,797.1590 -13,814.3990 -20,037.5730
Basic EPS
0.03 -1.56 -83.47 -158.75 -242.00
Diluted EPS
0.31 -1.56 -83.47 -158.75 -242.00
Basic Weighted Average Shares Outstanding
44,709.7510 28,065.3620 321.0390 87.0410 82.8080
Diluted Weighted Average Shares Outstanding
44,709.7510 28,065.3620 321.0390 87.0410 82.8080
Income Statement, Supplemental
EBIT
-3,394.3040 -4,756.9750 -1,076.9430 -8,142.3610 -19,455.7490
12/31/2022 - 12/2/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: